These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22827853)

  • 1. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
    Tang C; Godfrey T; Stawell R; Nikpour M
    Intern Med J; 2012 Sep; 42(9):968-78. PubMed ID: 22827853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A; West B
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Rodríguez-Hurtado FJ; Sáez-Moreno JA; Rodríguez-Ferrer JM
    Reumatol Clin; 2012; 8(5):280-3. PubMed ID: 22481059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current view on chloroquine derivative treatment from rheumatologist perspective and possible ocular side effects].
    Pawlak-Buś K; Gaca-Wysocka M; Grzybowski A; Leszczyński P
    Pol Merkur Lekarski; 2016 Mar; 40(237):202-6. PubMed ID: 27088206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
    Costedoat-Chalumeau N; Dunogué B; Leroux G; Morel N; Jallouli M; Le Guern V; Piette JC; Brézin AP; Melles RB; Marmor MF
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):317-26. PubMed ID: 25672591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 7. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
    Dos Reis Neto ET; Kakehasi AM; de Medeiros Pinheiro M; Ferreira GA; Marques CDL; da Mota LMH; Dos Santos Paiva E; Pileggi GCS; Sato EI; Reis APMG; Xavier RM; Provenza JR
    Adv Rheumatol; 2020 Jun; 60(1):32. PubMed ID: 32517786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hydroxychloroquine in lupus pregnancy: the British experience.
    Khamashta MA; Buchanan NM; Hughes GR
    Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 13. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine.
    Namazi MR
    Lupus; 2009 Feb; 18(2):104-5. PubMed ID: 19151110
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
    Chiang E; Jampol LM; Fawzi AA
    Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
    [No Abstract]   [Full Text] [Related]  

  • 17. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.
    Al-Bari MA
    J Antimicrob Chemother; 2015; 70(6):1608-21. PubMed ID: 25693996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drugs in pregnancy--the North American experience.
    Parke AL; Rothfield NF
    Lupus; 1996 Jun; 5 Suppl 1():S67-9. PubMed ID: 8803915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
    Doyno C; Sobieraj DM; Baker WL
    Clin Toxicol (Phila); 2021 Jan; 59(1):12-23. PubMed ID: 32960100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial drugs, pregnancy and lactation.
    Parke AL
    Lupus; 1993 Feb; 2 Suppl 1():S21-3. PubMed ID: 8485567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.